Cuba exposure profile · BMY · Health Care

Bristol Myers Squibb (BMY): Cuba Exposure Check

Independent audit of Bristol Myers Squibb's exposure to Cuba — OFAC SDN matches, Helms-Burton Title III risk, SEC filings, and the Cuban Insights news corpus.

No exposure on record

Bristol Myers Squibb has no Cuba exposure on the public record.

As of this scan, Bristol Myers Squibb (NYSE/NASDAQ: BMY) has no entries on the OFAC Cuba SDN program or the State Department Cuba Restricted List, no Cuba-related disclosures we have indexed in its recent SEC filings, and no Cuban-Insights-corpus news mentions. This is consistent with no operational, financial, or compliance exposure to Cuba — the default outcome under the Cuban Assets Control Regulations (CACR). Always re-verify against primary sources before relying on this as a compliance answer.

Ticker
BMY
S&P 500 sector
Health Care
Headquarters
New York City , New York
OFAC matches
0
EDGAR filings
0
Last refreshed
2026-04-21

OFAC Cuba SDN matches

No entry on the OFAC Cuba SDN list contains Bristol Myers Squibb as of the most recent OFAC scrape. Always re-verify with OFAC Sanctions Search before transacting.

SEC filings disclosing Cuba items

We searched Bristol Myers Squibb's SEC filings (10-K, 10-Q, 8-K, 20-F, 6-K) for the past two years and found no mention of Cuba, CACR, Helms-Burton, GAESA, or Havana. This is consistent with no material disclosed exposure. The full SEC full-text search is here: EDGAR full-text search for Bristol Myers Squibb .

Federal Register & news corpus mentions

No Federal Register notice or analyzed news article in our corpus references Bristol Myers Squibb in a Cuba context. Search the live sanctions tracker or the daily briefing index for ad-hoc context.
Methodology. This page combines four signals: (1) a hand-curated map of S&P 500 Cuba exposure maintained by Cuban Insights analysts; (2) fuzzy substring matching against every Cuba-program OFAC SDN designation and the State Department Cuba Restricted List (refreshed twice daily); (3) the SEC EDGAR full-text search across the company's 10-K, 10-Q, 8-K, 20-F, and 6-K filings for the past 24 months — including Helms-Burton Title III trafficking-claim disclosures; (4) a scan of our own analyzed-news corpus and US Federal Register notices. Last refreshed 2026-04-21. This is not legal or compliance advice; always verify with primary sources and qualified sanctions counsel before transacting.

Frequently asked questions

Is Bristol Myers Squibb (BMY) sanctioned by OFAC?
As of April 2026, Bristol Myers Squibb (BMY) is not listed on the OFAC CUBA-program SDN list. No direct or subsidiary entity match was found in our scan against the live US Treasury SDN feed. Note that the State Department's Cuba Restricted List and Cuba Prohibited Accommodations List apply separately and should be checked alongside the SDN. Always re-verify against the official OFAC Sanctions Search before relying on this for a compliance decision.
Does Bristol Myers Squibb have Cuba revenue exposure?
Bristol Myers Squibb has no Cuba exposure on the public record. As of this scan, Bristol Myers Squibb (NYSE/NASDAQ: BMY) has no entries on the OFAC Cuba SDN program or the State Department Cuba Restricted List, no Cuba-related disclosures we have indexed in its re
Has Bristol Myers Squibb disclosed Cuba in its SEC filings?
No recent SEC filings by Bristol Myers Squibb (BMY) contain Cuba, Helms-Burton, CACR, or Havana references in our EDGAR search across 10-K, 10-Q, 8-K, 20-F, and 6-K forms over the last 24 months. Use SEC EDGAR's full-text search to verify.

Useful tools